Health
EyePoint Reports DURAVYU Trial Data for Wet AMD
EyePoint, Inc. has released topline results from LUGANO, the first of two pivotal Phase 3 clinical trials for DURAVYU (vorolanib intravitreal insert) in treating wet age-related macular degeneration\u2026







